Timing of Remdesivir Initiation and Clinical Outcomes in Hospitalized Patients with COVID-19 Who Are at High Risk of Disease Progression in Japan: A Health Insurance Claims Database Study.

Saved in:
Bibliographic Details
Title: Timing of Remdesivir Initiation and Clinical Outcomes in Hospitalized Patients with COVID-19 Who Are at High Risk of Disease Progression in Japan: A Health Insurance Claims Database Study.
Authors: Shindo Y; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan., Piao Y; Gilead Sciences, K.K., 16/F GRAN TOKYO SOUTH TOWER, 1-9-2 Marunouchi, Chiyoda-ku, Tokyo 100-6616, Japan., Berry M; Gilead Sciences, Inc., 333 Lakeside Dr., Foster City, CA 94405, USA., Ramroth H; Gilead Sciences, EU, 2 Roundwood Ave., Uxbridge UB11 1AF, UK., Yoshida M; Gilead Sciences, K.K., 16/F GRAN TOKYO SOUTH TOWER, 1-9-2 Marunouchi, Chiyoda-ku, Tokyo 100-6616, Japan.
Source: Viruses [Viruses] 2026 Apr 21; Vol. 18 (4). Date of Electronic Publication: 2026 Apr 21.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1999-4915
DOI:10.3390/v18040479